Phase 3 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with cervical cancer confirmed by a tissue biopsy (histological diagnosis)
- People whose cervical cancer is one of these specific types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
- People who have already had surgery to remove the uterus and nearby lymph nodes (radical hysterectomy and pelvic lymphadenectomy)
- People whose post-surgery pathology results show at least one of the following: cancer spread to pelvic lymph nodes, cancer involvement in the tissue beside the cervix (parametrium), or cancer cells found at the edges of the removed tissue (positive surgical margins) — meaning radiation therapy after surgery is recommended
- People aged 20 to 75 years old
- People who are in good general physical condition, rated 0 or 1 on a standard activity scale (ECOG scale), assessed within one week before joining the study (confirm with trial site)
- People whose blood counts meet minimum levels: white blood cell component (granulocytes) at or above 1.0 x 10³/µL, platelets at or above 30 x 10³/µL, and haemoglobin at or above 9.5 g/dL
- People whose kidney and liver function blood test results fall within acceptable ranges: creatinine below 2.0 mg/dL and bilirubin below 1.5 mg/dL
- People who have voluntarily signed the study consent form
Who may not be able to join:
- People whose cancer has spread to distant parts of the body, including the ovaries or lymph nodes near the main abdominal artery (para-aortic lymph nodes)
- People who have previously received radiation therapy to the pelvic area
- People whose surgery (radical hysterectomy) was performed more than 3 months before joining the study
- People who have a serious, untreated acute illness — such as stroke, cerebral infarction, or heart attack — unrelated to their cervical cancer
- People who received chemotherapy before their surgery (neoadjuvant chemotherapy)
- People who will not be receiving chemotherapy at the same time as their radiation therapy
- People who have been diagnosed with another cancer in the past 5 years, except for thyroid cancer, skin cancer, or carcinoma in situ (a very early-stage localised cancer)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-10-9933-2616
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Local control rate for the radiation treatment area
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.